33
Employees Affected
87%
Percentage
Geron Corporation announced a strategic restructuring that will reduce its workforce by approximately one-third, resulting in around 87 job cuts from its current 260 employees. The biopharmaceutical company said the layoffs are intended to lower operating expenses below 2025 levels, with cost savings expected to begin in the first quarter of 2026. Geron’s stock is down nearly 64 percent year to date